-+ 0.00%
-+ 0.00%
-+ 0.00%

Morgan Stanley Maintains Equal-Weight on Biogen, Raises Price Target to $224

Benzinga·06/18/2026 12:06:20
Listen to the news
Morgan Stanley analyst Matthew Harrison maintains Biogen (NASDAQ:BIIB) with a Equal-Weight and raises the price target from $206 to $224.